Dr. Stadtmauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
15 Penn Tower
Philadelphia, PA 19104Phone+1 215-662-3914- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1986 - 1989
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1983 - 1986
- Perelman School of Medicine at the University of PennsylvaniaClass of 1983
Certifications & Licensure
- PA State Medical License 1985 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Philadelphia Magazine Castle Connolly, 2005-2008, 2011-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Blood and Marrow Transplant Clinical Research Network Start of enrollment: 2001 Sep 01
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 784 citationsCRISPR-engineered T cells in patients with refractory cancerEdward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis, Adam D. Cohen, Kristy L. Weber
Science. 2020-02-28 - 605 citationsPlerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaJohn F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee, Ivana N. Micallef, Patrick J. Stiff
Blood. 2009-06-04 - 277 citationsCombined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma.Dan T. Vogl, Edward A. Stadtmauer, Kay See Tan, Daniel F. Heitjan, Lisa E. Davis
Autophagy. 2014-05-20
Journal Articles
- Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium Difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsEdward A Stadtmauer, James K Mangan, Elizabeth O Hexner, David L Porter, Daria V Babushok, Jacqueline Smith, Craig W Freyer, Mindy Schuster, Noelle V Frey, Selina M Lu..., Clinical Infectious Diseases
Abstracts/Posters
- Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple MyelomaEdward A. Stadtmauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)Edward A. Stadtmauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Lo...Edward A. Stadtmauer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Predictors of T Cell Expansion and Clinical Responses Following B-Cell Maturation Antigen-Specific Chimeric Antigen Receptor T Cell Therapy (CART-BCMA) for Relapsed/Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation Sequencing2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- The Cancer Tech Revolution: ‘We’re Not Far from a Diagnosis Being No Big Deal’May 17th, 2023
- Penn Medicine at the 2022 ASH MeetingDecember 8th, 2022
- Where Should Society Draw Ethical Lines for Experimental CRISPR Gene Therapies That Appear Able to Cure Diseases?April 13th, 2022
- Join now to see all
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: